Evidence map›Paper›PMID 25505742›Full record

ArticleGerms2014

Experimental approach for bacteriophage susceptibility testing of planktonic and sessile bacterial populations - Study protocol.

Alina Cristina Neguţ, Oana Săndulescu, Marcela Popa, Anca Streinu-Cercel, Zemphira Alavidze, Ioana Berciu, Coralia Bleotu, Mircea Ioan Popa, Mariana Carmen Chifiriuc, Adrian Streinu-Cercel

Open access · greenAbstract read
In one paragraph

Article in Germs, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Journal of medical microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Alina Cristina NeguţMD, PhD Student, Carol Davila University of Medicine and Pharmacy; National Institute for Infectious Diseases "Prof. Dr. Matei Balş", Bucharest, Romania.
Oana SăndulescuMD, Assistant Lecturer, Department of Infectious Diseases, Carol Davila University of Medicine and Pharmacy, National Institute for Infectious Diseases "Prof. Dr. Matei Balş", Bucharest, Romania.
Marcela PopaPhD Student, Microbiology Department, Faculty of Biology, University of Bucharest; Research Institute of the University of Bucharest, Romania.
Anca Streinu-CercelMD, PhD, Lecturer, Department of Infectious Diseases, Carol Davila University of Medicine and Pharmacy, National Institute for Infectious Diseases "Prof. Dr. Matei Balş", Bucharest, Romania.
Zemphira AlavidzePhD, Lead Scientist, "Eliava Biopreparation"; Phage Therapy Center, Tbilisi, Republic of Georgia.
Ioana BerciuMD, PhD Student, Department of Infectious Diseases, Carol Davila University of Medicine and Pharmacy; National Institute for Infectious Diseases "Prof. Dr. Matei Balş"
Coralia BleotuPhD, Microbiology Department, Faculty of Biology, University of Bucharest; Ştefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.
Mircea Ioan PopaMD, PhD, Professor, Department of Microbiology II, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Mariana Carmen ChifiriucPhD, Professor, Microbiology Department, Faculty of Biology, University of Bucharest; Research Institute of the University of Bucharest, Romania.
Adrian Streinu-CercelMD, PhD, Professor, Department of Infectious Diseases, Carol Davila University of Medicine and Pharmacy; National Institute for Infectious Diseases "Prof. Dr. Matei Balş", Bucharest, Romania.
Carol Davila University of Medicine and Pharmacy · ROUniversity of Bucharest · RONational Cancer Center of Georgia · GENational Institute of Allergy and Infectious Diseases · USRomanian Academy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAntimicrobial resistance is a growing threat for all clinical branches. This phenomenon poses important challenges in controlling infectious diseases. However, multidrug resistance is not the only issue, as bacteria that are otherwise susceptible to common antibiotics express other patterns for evading antibiotherapy, for example they can aggregate within a self-produced matrix to form biofilm.

methodsWe intend to perform a prospective laboratory study of the germs isolated from different samples collected from patients admitted with infectious pathology in reference hospitals in Romania. We will perform antibiotic resistance testing as well as phage testing, both on solid and liquid growth medium, for Staphylococcus spp., Enterococcus spp., and Pseudomonas spp. We intend to collect data for 150 patients with different infections with these identified pathogens. Phage susceptibility testing will be performed using 5 types of strain-specific bacteriophage mixtures: PYO, INTESTI, STAPHYLOCOCCAL (Eliava BioPreparations, Tbilisi, Georgia), PHAGYO, PHAGESTI (JSC "Biochimpharm", Tbilisi, Georgia). For phage-susceptible strains, we will evaluate biofilm formation in the presence of phages, as well as phage effect on already formed biofilm. EXPECTED

resultsThrough this study, we intend to provide the first set of results on bacteriophage-susceptibility of bacteria isolated from patients with hard to treat infections, from reference hospitals in Romania. By evaluating a large number of bacterial strains we aim to predict and project biofilm kinetics, while adding binary phage dilutions at key timepoints during biofilm formation. ACKNOWLEDGMENTS: POSDRU/159/1.5/S/141531; Carol Davila University of Medicine and Pharmacy, Young Researchers Grant no. 28341/2013.

Indexed as

Bacteriophagesbiofilmlysisplanktonic bacteriaspectrophotometry

Identifiers

PMID25505742
PMCPMC4258400
OpenAlexW2153483089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.